Federal contract award
HT942523C0103
MULTIPLEXED LATERAL FLOW BASED IMMUNOASSAY PROTOTYPE AND ASSOCIATED CELLPHONE BASED READER AND SOFTWARE FOR THE DETECTION OF VIRAL HEMORRHAGIC FEVER ANTIGENS AND ANTIBODIES.
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | ARMY MED RES ACQ ACTIVITY |
| NAICS | 541714 — Research and Development in Biotechnology (except Nanobiotechnology) |
| PSC | AJ11 — GENERAL SCIENCE AND TECHNOLOGY R&D SERVICES; GENERAL SCIENCE AND TECHNOLOGY; BASIC RESEARCH |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $558.2K |
| Current contract value | $558.2K |
| Potential contract value / ceiling | $558.2K |
| Start date | Sep 25, 2023 |
| Current end date | Sep 27, 2025 |
| Potential end date | Sep 27, 2025 |
| Latest award activity | Jun 24, 2024 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jun 24, 2024 | P00001 | $275.1K | CUSTOMIZED LATERAL FLOW IMMUNOASSAY |
| Sep 22, 2023 | 0 | $283.2K | MULTIPLEXED LATERAL FLOW BASED IMMUNOASSAY PROTOTYPE AND ASSOCIATED CELLPHONE BASED READER AND SOFTWARE FOR THE DETECTION OF VIRAL HEMORRHAGIC FEVER ANTIGENS AND ANTIBODIES. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.